By: IPP Bureau
Last updated : July 17, 2026 6:22 pm
New funding programme will back up to three physician-scientist-led projects focused on improving diagnosis, treatment and supportive care for blood disorders, with applications open until August 31, 2026
DKMS has launched the DKMS Impact Grant 2027, a new funding initiative aimed at supporting physician-scientists in Central and South America, Africa, and South and Southeast Asia, including India, to advance research and healthcare solutions for patients with hematological diseases.
The grant, funded by DKMS Stiftung Leben Spenden, will support up to three projects with funding of up to €120,000 over two years (€60,000 annually). Successful projects may also be eligible for a two-year extension following a positive evaluation. In addition to financial support, grantees may receive complimentary access to diagnostic services, including HLA typing, and scientific expertise from DKMS specialists.
Applications for the DKMS Impact Grant 2027 are open until August 31, 2026.
"Outstanding ideas are not limited by geography or resources. Through the DKMS Impact Grant, we want to empower physicians and scientists who understand the challenges in their healthcare systems best and enable them to develop solutions that create lasting benefits for patients. By investing in local innovation, we hope to improve access to hematology care where it is needed most," said Professor Dr. Thomas Klingebiel, Member of the Board of Trustees and long-standing consultant to DKMS.
According to DKMS, India has a vibrant medical and scientific community that continues to advance hematology despite disparities in access to specialised care across the country and the broader region.
The organisation said the new grant seeks to help physician-scientists translate innovative ideas into practical solutions that improve diagnosis, treatment and supportive care while strengthening local healthcare systems.
Eligible projects may focus on generating actionable clinical knowledge through research or implementing sustainable solutions to improve access to diagnosis, treatment, management of complications, supportive care and health system capacity for patients with hematological diseases.
The application process comprises two stages. Interested applicants must first submit a Letter of Intent, after which shortlisted candidates will be invited to submit a full proposal. Up to three projects will ultimately receive funding.
Researchers can find eligibility criteria and application details on the DKMS Professionals' Platform. Interested applicants may also contact DKMS through the programme's dedicated email for additional information.